|Dr. Dennis Clegg (University of California - Santa Barbara, CA)|
|Dr. Kathryn Bollinger (Medical College Of Georgia - Augusta, GA)|
Dr. Dennis Clegg, co-director of the University of California-Santa Barbara Center for Stem Cell Biology and Engineering, discusses how a stem cell derived retinal implant has survived for longer than two years with no immune rejection.
Then, Dr. Kathryn Bollinger, associate professor of ophthalmology, cellular biology, and anatomy at Augusta's Medical College of Georgia, explains how a protein, sigma 1 receptors, can protect retinal ganglion cells, which are damaged in glaucoma.
4/24/2022 Podcast (Click Image Below)